Veolia chooses Medclair for nitrous oxide destruction in new market
Idag, 09:30
Medclair AB has received a conditional order regarding a system solution for the destruction of nitrous oxide emissions from a company within the global environmental group Veolia. The deal, valued at approximately SEK 3.65 million, includes an installation for the destruction of nitrous oxide (N2O) from gas cylinders within the recycling industry.
Through this order, Medclair establishes a new significant customer relationship in a new geographical market in Europe for the company. Experience from previous collaborations with other units within the Veolia Group shows that solutions in this segment often lead to a long-term and recurring need among customers, which opens the door for further growth.
The installation is estimated to reduce the customer's carbon footprint by over 1.6 million kg N2O. The system is a proven solution for safely emptying and destroying nitrous oxide in gas cylinders, ensuring that the gas does not reach the atmosphere while simultaneously providing a safe working environment.
The investment is approved and budgeted by the customer. Delivery and the formal purchase order are conditional upon local authority permits, which are expected to be in place during the second half of 2026.
"We are very proud to welcome a new customer within the Veolia Group and at the same time take the step into a completely new geographical market for us. Within the recycling segment, we see a clear pattern where the first deal often serves as the starting point for a long-term collaboration with recurring orders. The fact that we are now establishing our technology for the destruction of gas cylinders in a new region is a testament to our strength, confirming the scalability and international potential of our solutions," says Jonas Lundh, CEO of Medclair.
For further information, please contact:
Jonas Lundh, Medclair AB (publ), Phone: +46 76 193 90 90, Email: jonas.lundh@medclair.com
About Us
Medclair is a Swedish cleantech company and a leader in safe and sustainable nitrous oxide management. With operations in twenty countries, Medclair provides innovative solutions that significantly reduce the climate impact of nitrous oxide while improving workplace safety.
The company is listed on NGM Nordic SME. For more information, please visit www.medclair.com.
Attachments
Veolia chooses Medclair for nitrous oxide destruction in new market
Ämnen i artikeln
Veolia chooses Medclair for nitrous oxide destruction in new market
Idag, 09:30
Medclair AB has received a conditional order regarding a system solution for the destruction of nitrous oxide emissions from a company within the global environmental group Veolia. The deal, valued at approximately SEK 3.65 million, includes an installation for the destruction of nitrous oxide (N2O) from gas cylinders within the recycling industry.
Through this order, Medclair establishes a new significant customer relationship in a new geographical market in Europe for the company. Experience from previous collaborations with other units within the Veolia Group shows that solutions in this segment often lead to a long-term and recurring need among customers, which opens the door for further growth.
The installation is estimated to reduce the customer's carbon footprint by over 1.6 million kg N2O. The system is a proven solution for safely emptying and destroying nitrous oxide in gas cylinders, ensuring that the gas does not reach the atmosphere while simultaneously providing a safe working environment.
The investment is approved and budgeted by the customer. Delivery and the formal purchase order are conditional upon local authority permits, which are expected to be in place during the second half of 2026.
"We are very proud to welcome a new customer within the Veolia Group and at the same time take the step into a completely new geographical market for us. Within the recycling segment, we see a clear pattern where the first deal often serves as the starting point for a long-term collaboration with recurring orders. The fact that we are now establishing our technology for the destruction of gas cylinders in a new region is a testament to our strength, confirming the scalability and international potential of our solutions," says Jonas Lundh, CEO of Medclair.
For further information, please contact:
Jonas Lundh, Medclair AB (publ), Phone: +46 76 193 90 90, Email: jonas.lundh@medclair.com
About Us
Medclair is a Swedish cleantech company and a leader in safe and sustainable nitrous oxide management. With operations in twenty countries, Medclair provides innovative solutions that significantly reduce the climate impact of nitrous oxide while improving workplace safety.
The company is listed on NGM Nordic SME. For more information, please visit www.medclair.com.
Attachments
Veolia chooses Medclair for nitrous oxide destruction in new market
Ämnen i artikeln
Rapporter
Analys
Rapporter
Rapporter
Analys
Rapporter
Marknadsöversikt
1 DAG %
Senast
1 mån
